Amgen CEO on cholesterol drug price cut: 'Too many patients' were struggling to pay

Jim Cramer sits down with Amgen Chairman and CEO Bob Bradway to hear about the company's recent price cut for one of its key drugs.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

CNBC /  🏆 12. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Apple CEO Tim Cook speaks with CNBC's Jim Cramer: Full transcriptApple CEO Tim Cook talked to CNBC's Jim Cramer about iPhone sales, the Chinese economy and the future of Apple.
Baca lebih lajut »

Apple CEO Tim Cook talks China, Wall Street negativity and innovation with CNBC's Jim CramerJim Cramer sits down with Apple CEO Tim Cook to discuss the company's recent guidance cut, U.S.-China trade talks an Apple's 'culture of innovation.'
Baca lebih lajut »

U.S. top court rejects Amgen over cholesterol medication patent fightThe U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to rei...
Baca lebih lajut »

Stocks making the biggest moves after hours: Apple, Amgen, AMD and moreSee which stocks are posting big moves after the bell on January 29.
Baca lebih lajut »